Vickie B.

San Antonio, TX

Vickie’s Testimonial for Cellular Therapy at the Lung Institute

Location: San Antonio, TX | Condition: COPD

Vickie B. was diagnosed with COPD several years ago. She used four to six breathing treatments to get herself through the workday. At home, she relied on oxygen therapy. Searching for alternatives to a highly-invasive lung transplant procedure, Vickie discovered cellular therapy at the Lung Institute. Vickie noticed positive changes within two-to-three weeks following treatment.

As she began to breathe more easily, she was able to become more active again. Visiting her pulmonologist three months after treatment, Vickie discovered that her lung function had significantly increased. Now, her lungs are functioning better than they have in a long time.

“Since my treatment in May, I am able to do things again that I haven’t done in months. Walking, shopping and seeing my family are just some of the things that I can do now,” says Vickie.

Vickie got a new lease on life with cellular therapy at the Lung Institute. If you suffer from chronic lung disease, perhaps you can too. If you would like more information, contact us today by calling 888-745-6697 to speak with one of our patient coordinators.

 

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.